Literature DB >> 33630879

Relationship between anthropometric and biochemical changes of metabolic syndrome with retinal nerve fiber layer and macular thickness.

Sze Hui New1,2, Sue Ngein Leow2, Suresh Kumar Vasudevan2, Idayu Badilla Idris3, Seng Fai Tang1, Norshamsiah Md Din1.   

Abstract

OBJECTIVE: To evaluate the retinal nerve fiber layer (RNFL) and macular thicknesses and identify systemic risk factors for thinning of these layers in patients with metabolic syndrome (MetS).
METHODOLOGY: A cross-sectional observational study was performed on patients diagnosed with MetS and compared to normal controls. All patients underwent ophthalmic and anthropometric examination, serological and biochemical blood investigations; and ocular imaging using spectral-domain optical coherence tomography. Patients with ocular pathology were excluded. Unpaired t-test was used to compare mean thickness between the two groups. One-way ANOVA with Bonferroni correction for multiple comparisons was used to compare mean thickness between different tertiles of MetS parameters, and a generalized estimating equation was used to correct for inter-eye correlation and to assess association between mean thickness and covariates.
RESULTS: Two hundred and forty-eight eyes from 124 participants (1:1 ratio of MetS patients to controls) were included. Age ranged between 30 to 50 years old, and mean age was 40 ± 6.6 years. RNFL thickness was lower globally (93.6 ± 9.9 μm vs 99.0 ± 9.3, p<0.001) and in the inferior (124.5 ± 17.5 μm vs 131.0 ± 16.4 μm, p = 0.002), superior (117.2 ± 16.0 μm vs 126.3 ± 14.4 μm, p<0.001) and temporal (65.5 ± 10.2 μm vs 69.5 ± 9.8, p = 0.002) sectors in MetS patients compared to controls. Only the central (237.0 ± 14.0 μm vs 243.6 ± 18.0 μm, p = 0.002) and inferior parafoveal (307.8 ± 20.9 vs 314.6 ± 14.6, p = 0.004) area of the macula was significantly thinner. The inferior RNFL sector had the most difference (mean difference = 9.1 μm). The Generalized Estimating Equation found that, after adjusting for age, diastolic blood pressure, BMI, HDL and obesity; the number of MetS components and elevated triglyceride levels were independent risk factors for reduced thickness in global RNFL (β = -4.4, 95% CI = -7.29 to -1.5, p = 0.003) and inferior parafovea (β = -6.85, 95% CI = -11.58 to -2.13, p = 0.004) thickness respectively.
CONCLUSION: RNFL thinning was seen more than macula thinning in MetS patients, suggesting RNFL susceptibility to neurodegeneration than the macula. A higher number of metabolic components and elevated triglyceride levels were independent risk factors for retinal thinning in this group of patients.

Entities:  

Year:  2021        PMID: 33630879      PMCID: PMC7906412          DOI: 10.1371/journal.pone.0246830

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  25 in total

1.  Neuroretinal rim width ratios in morphological glaucoma diagnosis.

Authors:  J B Jonas; W M Budde; P Lang
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

Review 2.  New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic review.

Authors:  Eline E B De Clerck; Jan S A G Schouten; Tos T J M Berendschot; Alfons G H Kessels; Rudy M M A Nuijts; Henny J M Beckers; Miranda T Schram; Coen D A Stehouwer; Carroll A B Webers
Journal:  Lancet Diabetes Endocrinol       Date:  2015-07-13       Impact factor: 32.069

3.  Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy.

Authors:  A M Shahidi; G P Sampson; N Pritchard; K Edwards; D Vagenas; A W Russell; R A Malik; N Efron
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

4.  Influence of diabetes on macular thickness measured using optical coherence tomography: the Singapore Indian Eye Study.

Authors:  C C A Sng; C Y Cheung; R E Man; W Wong; R Lavanya; P Mitchell; T Aung; T Y Wong
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

5.  Advanced glycation end products in human optic nerve head.

Authors:  S Amano; Y Kaji; T Oshika; T Oka; R Machinami; R Nagai; S Horiuchi
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

6.  Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.

Authors:  Atsuhito Saiki; Takeyoshi Murano; Fusako Watanabe; Tomokazu Oyama; Yoh Miyashita; Kohji Shirai
Journal:  J Atheroscler Thromb       Date:  2005       Impact factor: 4.928

7.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

8.  Metabolic syndrome as a risk factor in normal-tension glaucoma.

Authors:  Mijin Kim; Jin Wook Jeoung; Ki Ho Park; Won Hyuck Oh; Hyuk Jin Choi; Dong Myung Kim
Journal:  Acta Ophthalmol       Date:  2014-05-19       Impact factor: 3.761

9.  Comparison of the nerve fiber layer of type 2 diabetic patients without glaucoma with normal subjects of the same age and sex.

Authors:  Alexandros Takis; Dimitrios Alonistiotis; Dimitrios Panagiotidis; Nikolaos Ioannou; Dimitris Papaconstantinou; Panagiotis Theodossiadis
Journal:  Clin Ophthalmol       Date:  2014-02-25

Review 10.  The Global Epidemic of the Metabolic Syndrome.

Authors:  Mohammad G Saklayen
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.